Hikma Pharmaceuticals PLC.

In News

Hikma Pharmaceuticals slips Friday, underperforms market - MarketWatch

MarketWatch - Mar 27, 2026

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines - PR Newswire

PR Newswire - Jun 28, 2025

Hikma Pharma tumbles on softer guidance as buyback fails to soften pill - Proactive financial news

Proactive financial news - Feb 26, 2026

Amarin Tells Justices Hikma Drug Patent Appeal Threatens IP - Law360

Law360 - Mar 24, 2026

Brookfield confirms it will not make offer for Hikma Pharmaceuticals - Investing.com

Investing.com - Feb 04, 2026

Hikma Pharmaceuticals Delivers 2025 Revenue Growth In Line With Guidance - DirectorsTalk Interviews

DirectorsTalk Interviews - Feb 26, 2026

Mtor Inhibitors Market Is Going to Boom |Novartis AG, Hikma - openPR.com

openPR.com - Mar 27, 2026

Hikma Pharmaceuticals PLC (LON:HIK) is favoured by institutional owners who hold 59% of the company - Yahoo Finance

Yahoo Finance - Sep 19, 2025

Hikma, IFC sign $250mn deal, marking a 40-year partnership driving access to quality medicines in the MENA region - International Finance Corporation (IFC)

International Finance Corporation (IFC) - Jul 15, 2025

Hikma Must Share Vascepa Copy Records as High Court Weighs Case - news.bloomberglaw.com

news.bloomberglaw.com - Jan 14, 2026

Hikma Pharmaceuticals PLC Stock: A Steady Player in Global Generics with Strong Injectables Focus fo - ad-hoc-news.de

ad-hoc-news.de - Mar 28, 2026

Hikma Pharmaceuticals gains amid takeover speculation - MSN

MSN - Feb 04, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment